Can Fite Biofarma Stock (AMEX: CANF) stock price, news, charts, stock research, profile.
Open | $1.960 |
Close | - |
Volume / Avg. | 3.127K / 20.456K |
Day Range | 1.930 - 1.960 |
52 Wk Range | 1.680 - 3.330 |
Market Cap | $10.380M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 36 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Can Fite Biofarma (AMEX: CANF) through any online brokerage.
Other companies in Can Fite Biofarma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
The latest price target for Can Fite Biofarma (AMEX: CANF) was reported by HC Wainwright & Co. on Tuesday, October 24, 2023. The analyst firm set a price target for 18.00 expecting CANF to rise to within 12 months (a possible 825.45% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Can Fite Biofarma (AMEX: CANF) is $1.945 last updated Today at April 24, 2024 at 2:31 PM EDT.
There are no upcoming dividends for Can Fite Biofarma.
Can Fite Biofarma’s Q1 earnings are confirmed for Thursday, May 30, 2024.
There is no upcoming split for Can Fite Biofarma.
Can Fite Biofarma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.